PED financial statements and SEC filings
PED annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $45.75M | -$7.86M | -$10.36M | 10-K |
| 2024-12-31 | $39.55M | $4.72M | $12.29M | 10-K |
| 2023-12-31 | $30.78M | $1.24M | $1.70M | 10-K/A |
| 2022-12-31 | $30.03M | $2.63M | $2.84M | 10-K |
| 2021-12-31 | $15.86M | -$1.87M | -$1.30M | 10-K |
| 2020-12-31 | $8.06M | -$33.82M | -$32.69M | 10-K |
PED annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $375.87M | $168.50M | $207.36M | 10-Q |
| 2024-12-31 | $128.35M | $12.74M | $115.60M | 10-K |
| 2023-12-31 | $122.74M | $21.29M | $101.45M | 10-K/A |
| 2022-12-31 | $116.11M | $19.65M | $96.46M | 10-K |
| 2021-12-31 | $98.22M | $6.74M | $91.48M | 10-K |
| 2020-12-31 | $79.56M | $3.93M | $75.64M | 10-K |
PED annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | $10.76M | $0.00 | $122.14M | 10-K |
| 2024-12-31 | $12.77M | -$169.00K | $0.00 | 10-K |
| 2023-12-31 | $23.48M | -$45.00K | $0.00 | 10-K/A |
| 2022-12-31 | $15.98M | $0.00 | $35.00K | 10-K |
| 2021-12-31 | $5.97M | -$35.00K | $14.69M | 10-K |
| 2020-12-31 | $12.00K | $0.00 | $370.00K | 10-K |